【参考文献】
  1 Massague J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends Cell biol ,1994;4(5):172-178

2 Constam Db, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol ,1992;148(5):1404-1410

3 Peress NS, Perillo E. TGF-beta 2 and TGF-beta 3 immunoreactivity within the ciliary epithelium. Invest Ophthalmol Vis Sci,1994;35(2):453-457

4 Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, brousse N, Amigorena S, Hermine O, Durandy A. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol ,1999;162(8):4567-4575

5 border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest ,1992 ;90(1):1-7

6 Streilein JW. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol ,1990;35(1):67-73

7 Li XY, D'Orazio LT, Niederkorn JY. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology ,1996;89(1):34-40

8 She SC, Steahly LP, Moticka EJ. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci ,1990;31(10):1950-1956

9 Okamoto S, Hara Y, Streilein JW. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells. Transplantation ,1995;59(3):377-381

10 Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci ,1996;37(13):2700-2707

11 Tsukahara R, Takeuchi M, Akiba H, Kezuka T, Takeda K, Usui Y, Usui M, Yagita H, Okumura K. Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation. Int Immunol ,2005;17(5):523-530

12 Streilein JW, Wilbanks GA, Taylor A, Cousins S. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review. Curr Eye Res ,1992;11:41-47

13 Sano Y, Okamoto S, Streilein JW. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes. Curr Eye Res ,1997;16(11):1171-1174

14 Yang Y, Zhou SB. Immunosuppressive action of transforming growth factor beta1 after corneal transplantation. Int J Ophthalmol(Guoji Yanke Zazhi) ,2006;6(4):851-853

15 Li Q, Xi XH. Research development of the preventions and treatments of immunological rejection after corneal transplantation. Int J Ophthalmol(Guoji Yanke Zazhi) ,2006;6(5):1126-1129

16 Rocha G, Deschenes J, Rowsey JJ. The immunology of corneal graft rejection. Crit Rev Immunol ,1998;18(4):305-325

17 Sporn Mb, Roberts Ab. Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA ,1989;262(7):938-941

18 Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine ,1992;4(1):1-5

19 Liu YP, Liu L. Cytokines and corneal transplantation immunology. Int J Ophthalmol(Guoji Yanke Zazhi) ,2004;4(3):481-484

20 Carel JC, Sheehan KC, Schreiber RD, Lacy PE. Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor. Transplantation ,1993;55(2):456-458

21 Gill RG. Transforming growth factor beta prevents islet allograft rejection. Transplant Proc ,1991;23(1 Pt 1):747-748

22 Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med ,1990;172(6):1777-1784

23 Waltenberger J, Miyazono K, Funa K, Wanders A, Fellstrom b, Heldin CH. Transforming growth factor-beta and organ transplantation. Transplant Proc ,1993;25(2):2038-2040

24 Qin L, Chavin KD, Ding Y, Woodward JE, Favaro JP, Lin J, bromberg JS. Gene transfer for Transplantation. Prolongation of allograft survival with transforming growth factor-beta 1. Ann Surg ,1994;220(4):508-518

25 beauchamp RD, Sheng HM, bascom CC, Miller DA, Lyons RM, Torre-Amione G, Moses HL. Phenotypic alterations in fibroblasts and fibrosarcoma cells that overexpress latent transforming growth factor-beta 1. Endocrinology ,1992;130(5):2476-2486

上一页  [1] [2] [3] [4]